1. Home
  2. VRME vs INDP Comparison

VRME vs INDP Comparison

Compare VRME & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VerifyMe Inc.

VRME

VerifyMe Inc.

HOLD

Current Price

$0.78

Market Cap

11.3M

Sector

Technology

ML Signal

HOLD

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

N/A

Current Price

$1.76

Market Cap

4.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VRME
INDP
Founded
1999
2000
Country
United States
United States
Employees
41
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.3M
4.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
VRME
INDP
Price
$0.78
$1.76
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$1.50
N/A
AVG Volume (30 Days)
139.7K
17.8K
Earning Date
03-30-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$0.27
52 Week High
$1.51
$13.24

Technical Indicators

Market Signals
Indicator
VRME
INDP
Relative Strength Index (RSI) 30.59 44.39
Support Level $0.66 $1.64
Resistance Level $0.81 $1.99
Average True Range (ATR) 0.06 0.10
MACD -0.01 0.01
Stochastic Oscillator 12.54 37.84

Price Performance

Historical Comparison
VRME
INDP

About VRME VerifyMe Inc.

VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

Share on Social Networks: